# Palvella Therapeutics, Inc.: Form S-1/A, filed Jan 14, 2025

- Company: [Palvella Therapeutics, Inc.](/companies/pvla.md) (CIK 1583648)
- Form: S-1/A
- Filed: 2025-01-14
- Accepted by EDGAR: Jan 14, 2025, 06:22 ET
- Period: not reported
- Accession: 0001437749-25-001017
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1583648/000143774925001017/pirs20250108c_s1a.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1583648/000143774925001017/

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1583648/000143774925001017/pirs20250108c_s1a.htm

Filed Jan 14, 2025.
Source: SEC EDGAR, the filing index for accession 0001437749-25-001017. Last ingested by Listed: Nov 5, 2026, 12:13 ET. No prices; not investment advice.